Oesophageal cancer, Secondary cancers, Stomach cancer
Open
Phase 2
This trial is looking at sonesitatug vedotin and rilvegostomig with capecitabine or 5-FU for stomach cancer and cancer where the food pipe joins the stomach.
It is open to people with stomach cancer and cancer where the food pipe joins the stomach (gastro oesophageal cancer) that:
has spread to another part of the body or cannot be removed with surgery and
has not been treated
You pronounce sonesitatug vedotin as soh-nee-sit-uh-tug veh-doh-tin. Sonesitatug vedotin is also called AZD0901.
You pronounce rilvegostomig as ril–veh–gost-oh-mig.
Recruitment start: 13 May 2026
Recruitment end: 30 June 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Elizabeth Smyth
AstraZeneca
Last reviewed: 21 Sept 2026
CRUK internal database number: 20193